Articles

Thiazide-induced hyponatremia is associated with an increased risk of fracture, but this is due to confounding factors, not hyponatremia itself, researchers at the Chinese University of Hong Kong have found.

Treatment of early rheumatoid arthritis patients with tumor necrosis factor antagonists produces no reduction in the risk of acute coronary syndrome, researchers in Sweden have found.

As the year comes to a close, one cannot help but reflect on the astounding technological advancements made in 2011, particularly since such progress has greatly benefited the medical industry.

A recently published paper in the medical journal Pediatrics argues that there is finally strong enough evidence for doctors to recommend that infants and children who have asthma or are at risk for the disease avoid acetaminophen.

According to a recent longitudinal study, the prevalence of acid reflux has risen significantly over the past decade, with women in particular more susceptible to the ailment as they aged than men.

A recent study has found that the children of women exposed to elevated levels of DDE while they were pregnant had increased rates of pneumonia and bronchitis in their first year of life.

A vaccine that significantly decreases tumors in a mouse model closely imitating 90% of human breast and pancreatic cancer cases—including ones that do not respond to traditional therapies—has been developed by Mayo Clinic researchers.

Aptamer-based proteomics array technology from Somalogic, Inc. could enable diagnosis of pancreatic cancer and mesothelioma at earlier stages.

For the first time ever, a US government advisory board has asked several scientific journals to withhold details of experiments out of concern that terrorists could use the information in question to create deadly pathogens and trigger epidemics.

Early intervention programs designed to help parents of premature infants better understand their children’s needs can significantly reduce behavioral problems later in life, researchers in Norway have found.

The US Food and Drug Administration has accepted for review a New Drug Application for tofacitinib from Pfizer Inc.

A phase 3 clinical trial has found no statistical superiority between two multiple-sclerosis (MS) treatments, Aubagio (teriflunomide) and Rebif (interferon beta 1-a).

Women with endometriosis are much more likely to develop inflammatory bowel disease than women without the reproductive disorder.

A majority of practitioners in the United Kingdom advise patients suffering from chronic lower back pain to take a break from work to recuperate, even though guidelines call for patients to remain active and continue working.

Based on a 12-year longitudinal study, researchers have found that 63% of women over 50 report persistent, incident, or intermittent knee pain.

New guidelines from the US Advisory Committee on Immunization Practices (ACIP) advise all diabetes patients between the ages of 19 and 59 to receive the hepatitis B vaccination and urge those over the age of 60 to consult a physician prior to receiving the vaccine.

The FDA mandated a new safety warning for the heart rhythm drug Multaq after studies showed that it doubled the risk of heart-related complications in patients with permanent atrial fibrillation.

Ardea Biosciences announced on Monday that it would soon begin the first of four planned Phase 3 clinical trials of its experimental gout drug lesinurad.

A strictly controlled diet allowed obese knee osteoarthritis patients to lose weight while increasing levels of key nutrients and maintaining total bone mineral content and bone mineral density, researchers in Denmark have found.

A study involving more than 150,000 adult users of attention deficit hyperactivity disorder drugs has found no evidence of a link between the medications and increased risk of heart attack, stroke, or sudden cardiac death.